Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
From Cuff Arthropathy to Reverse Shoulder Arthroplasty - a Multicentre Randomized Control Trial (Study 1: Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?).
Lovisenberg Diakonale Hospital
130 participants
Sep 15, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.
Eligibility
Inclusion Criteria2
- Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis
- Able to read or write Norwegian
Exclusion Criteria8
- Severe osteoporosis
- Osteonecrosis of the humeral head
- Dementia
- Poor deltoid function
- Revision surgery
- ASA IV
- Suspected chronic infection
- Acute fracture
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bony increased offset-reversed shoulder arthroplasty(BIO-RSA) will be performed.
Conventional reversed shoulder arthroplasty(RSA) will be performed.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06025331